NICE recommends infliximab and adalimumab for Crohn's disease treatment | News | Nursing Times

Links shared publicly online about this topic.

1,339
total visits

NICE recommends infliximab and adalimumab for Crohn's disease treatment | News | Nursing Times

In final draft guidance published today (4 March) NICE has recommended infliximab and adalimumab as treatment options for people with severe, active Crohn's disease whose condition has not responded to conventional therapy, or who are intolerant of or have contraindications to conventional therapy.

View full resource at nursingtimes.net

Tags: Crohn's Disease, Crohn's Disease Medication, Ulcerative Colitis Medication, Rheumatoid Arthritis Medication, Disease and Condition, Remicade, Humira, Nursing